Prescription switching: Rationales and risks-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prescription switching: Rationales and risks

Published:2019-10-07 Issue:1 Volume:74 Page:
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clin Pract

Author:

Kirby Michael G.¹^ORCID,Allchorne Paula²,Appanna Tim³,Davey Patrick⁴,Gledhill Richard⁵,Green James S. A.²,Greene Damian⁶,Rosario Derek J.⁷

Affiliation:

1. The Prostate Centre London UK

2. Barts Health NHS Trust The Royal London Hospital London UK

3. Royal Glamorgan Hospital Llantrisant UK

4. Northampton General Hospital Northampton UK

5. Queen Elizabeth Hospital Birmingham UK

6. Sunderland Royal Hospital Sunderland UK

7. Royal Hallamshire Hospital Sheffield UK

Funder

Ferring

Publisher

Hindawi Limited

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijcp.13429

Reference93 articles.

1. Potential problems and recommendations regarding substitution of generic antiepileptic drugs: a systematic review of literature

2. Degarelix: A Review of Its Use in Patients with Prostate Cancer

3. Safety of Switching Factor VIII Products in the Era of Evolving Concentrates: Myths and Facts

4. Switching of platelet P2Y12 receptor inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Review of the literature and practical considerations

5. Switching and stopping antidepressants;Keks N;Aust Prescr,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Managing polypharmacy through medication review tools – pros and cons;Folia Medica;2024-04-30

2. Patient-Reported Reasons for Switching or Discontinuing Statin Therapy: A Mixed Methods Study Using Social Media;Drug Safety;2022-08-07

3. Patient Reported Reasons for Switching or Discontinuing Statin Therapy: A Mixed Methods Study Using Social Media;SSRN Electronic Journal;2022

4. Targeting the Mevalonate Pathway in Cancer;Trends in Cancer;2021-06

5. Cardiovascular risk profiles of GnRH agonists and antagonists: real-world analysis from UK general practice;World Journal of Urology;2020-09-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3